| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000028615 |
| Receipt No. | R000032726 |
| Official scientific title of the study | A prospective registry evaluating angiographic and clinical outcomes after treatment with directional coronary atherectomy in patients with ischemic heart disease |
| Date of disclosure of the study information | 2017/08/10 |
| Last modified on | 2017/08/09 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A prospective registry evaluating angiographic and clinical outcomes after treatment with directional coronary atherectomy in patients with ischemic heart disease | |
| Title of the study (Brief title) | DCA registry | |
| Region |
|
|
| Condition | ||
| Condition | Coronary artery disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess angiographic and clinical outcomes after treatment with directional coronary atherectomy using intravascular ultrasound in patients with ischemic heart disease |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Angiographic restenosis at 12 months |
| Key secondary outcomes | All-cause death, cardiac death, myocardial infarction, target vessel revascularization, target lesion revascularization after procedure, at 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. Success rate of percutaneous coronary intervention. Periprocedural complications including bleeding, coronary perforation, rupture, dissection, spasm, acute occlusion, and shock. Changes in angiographic findings. Changes in lumen area, plaque burden, total atheroma volume, and percent atheroma volume by intravascular ultrasound. Bleeding during follow-up by the BARC bleeding definition, TIMI bleeding criteria, or GUSTO bleeding criteria. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with ischemic heart disease undergoing percutaneous coronary intervention with directional coronary atherectomy
2) Patients who have provided written informed consent |
|||
| Key exclusion criteria | 1) Patients who are intolerant to antiplatelet drugs
2) Patients who are intolerant to anticoagulant drugs 3) Patients who are considered inappropriate by the physicians |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Yasunori Nishida |
| Organization | Koseikai Takai Hospital |
| Division name | Cardiovascular Medicine |
| Address | 470-8 Kuranosho-cho, Tenri-city, Nara Japan |
| TEL | 0743655552 |
| nishida@takai-hp.com | |
| Public contact | |
| Name of contact person | Hiroshi Ueda |
| Organization | Koseikai Takai Hospital |
| Division name | Cardiovascular Medicine |
| Address | 470-8 Kuranosho-cho, Tenri-city, Nara Japan |
| TEL | 0743655552 |
| Homepage URL | |
| h-ueda@takai-hp.com | |
| Sponsor | |
| Institute | Koseikai Takai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Koseikai Takai Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032726 |